Intravesical LGG VS Saline Bladder Wash RCT
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedstar Health Research Institute
About this trial
This is the first ever comparative effectiveness study of an antibiotic-sparing novel self-management intervention to prevent complicated urinary tract infection (UTI).
Eligibility criteria
Qualifiers
Age ≥18 years;
SCI at least 6 months duration;
NLUTD (as determined by their SCI physician or urologist);
Utilizing intermittent catheterization for bladder management; and
Disqualifiers
Known genitourinary pathology beyond neuropathic bladder (i.e., vesicoureteral reflux, bladder or kidney stones, etc.);
Use of prophylactic antibiotics;
Instillation of intravesical agents (e.g., gentamycin, saline; or Lactobacillus);
Immunodeficiency;
Trial design
Treatments tested in this trial
- Lactobacillus RhamnosusGG
- Saline bladder wash
Treatment groups
120 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov